Although the end of the COVID-19 pandemic in the U.S. appears to be in sight, the mental health consequences of the pandemic, as well as rising rates of antidepressant use in the past decade, reveal another public health crisis. Antidepressant use has skyrocketed since 1999, leading it to become one of the most popular types […]
Tag: big pharma
The Cost of Staying Alive
In 1920, a diagnosis with diabetes was a death sentence. 100 years later, the prognosis for many Americans is only slightly more optimistic. There is a drug on the market that allows patients with Type 1 Diabetes to live relatively normal lives: insulin. However, the skyrocketing prices of the drug cause many Americans to think […]
Monsanto’s Plight: Seeds of Anger
When the rich and powerful try to work together to become even bigger, backlash can be expected. German pharmaceutical giant Bayer’s agreed acquisition of American agricultural biochemical company Monsanto for $66 billion (a $128/share valuation) was no exception. The impending Bayer-Monsanto merger has already acquired negative reviews, in part due to antitrust concerns and in […]
The Cost of Cost Relief: The potential impact of California’s drug price reform initiative
Government regulation is at it again. This time, it’s going after Big Pharma. California is the latest state to propose a ballot measure that, if passed, would set a price ceiling on prescription drugs paid for by state agencies. The California Drug Price Relief Initiative, proposed by the AIDS Healthcare Foundation, a Los Angeles-based patient […]
Ebola Ethics
Sporadically emerging from its natural reservoirs, the Ebola virus has recently captured global attention. Looming over West Africa, the Ebola pandemic has been transmitted and transported over national boundaries, now finding itself on U.S. soil. But the Ebola virus is not new; this disease was first noted in Zaire, the predecessor of the Democratic Republic […]